Michigan State University and the University of Michigan will take part in a major clinical study to test the effectiveness of a nutritional supplement called creatine in slowing the progression of Parkinson's disease. The institutions are two of about 50 sites around the country selected to take part in a National Institutes of Health Study. While creatine is not an approved therapy for the disease or any other condition, it is widely thought to improve exercise performance.